Free Trial

enGene (ENGN) 10K Form and Latest SEC Filings 2026

enGene logo
$1.60 -0.07 (-4.19%)
Closing price 04:00 PM Eastern
Extended Trading
$1.63 +0.03 (+1.62%)
As of 05:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest enGene SEC Filings & Recent Activity

enGene (NASDAQ:ENGN) has submitted 161+ documents to the U.S. Securities and Exchange Commission (SEC) since 2023. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on June 10, 2026.

8-K
enGene Files Current Report on Jun. 10, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
enGene Files Quarterly Report on Mar. 9, 2026

The 10-Q contains enGene's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

enGene SEC Filing History

Browse enGene's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
06/10/2026 3:09 PM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2026 12:12 PM
Cormorant Asset Management, LP (1583977) Filed by
enGene (1980845) Subject
Form SCHEDULE 13G/A
05/14/2026 9:30 AM
BML Investment Partners, L.P. (1373604) Filed by
enGene (1980845) Subject
Form SCHEDULE 13G/A
05/13/2026 8:23 PM
BML Investment Partners, L.P. (1373604) Filed by
enGene (1980845) Subject
Form SCHEDULE 13G
05/08/2026 3:06 PM
enGene (1980845) Filer
Form DEF 14A
05/07/2026 6:11 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2026 9:59 AM
enGene (1980845) Subject
Invus Global Management, LLC (2005369) Filed by
Form SCHEDULE 13G/A
04/09/2026 3:02 PM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2026 11:20 AM
enGene (1980845) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/09/2026 6:25 AM
enGene (1980845) Filer
Form 424B5
03/09/2026 6:09 AM
enGene (1980845) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/09/2026 6:15 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2026 6:04 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2026 11:15 PM
enGene (1980845) Filer
Form EFFECT
02/19/2026 3:25 PM
enGene (1980845) Filer
Form S-3
Registration statement under Securities Act of 1933  
02/17/2026 5:09 PM
enGene (1980845) Subject
Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by
Form SCHEDULE 13G/A
02/17/2026 2:00 PM
Cormorant Asset Management, LP (1583977) Filed by
enGene (1980845) Subject
Form SCHEDULE 13G
02/17/2026 11:46 AM
enGene (1980845) Subject
Kynam Capital Management, LP (1907884) Filed by
Form SCHEDULE 13G/A
01/27/2026 1:18 PM
enGene (1980845) Subject
Invus Global Management, LLC (2005369) Filed by
Form SCHEDULE 13G
01/21/2026 6:38 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 3:11 PM
enGene (1980845) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/22/2025 3:04 PM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2025 7:12 AM
Deep Track Capital, LP (1856083) Filed by
enGene (1980845) Subject
Form SCHEDULE 13G/A
11/14/2025 6:01 AM
enGene (1980845) Filer
Form 424B5
11/12/2025 5:16 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2025 6:36 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2025 3:44 PM
enGene (1980845) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/11/2025 3:08 PM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2025 3:11 PM
enGene (1980845) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/03/2025 6:56 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025 3:09 PM
Boyd Matthew Ross (2077001) Reporting
enGene (1980845) Issuer
Form 3
Initial statement of beneficial ownership of securities  
07/14/2025 3:10 PM
Boyd Matthew Ross (2077001) Reporting
enGene (1980845) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2025 3:10 PM
enGene (1980845) Issuer
Grossman William (1730229) Reporting
Form 3
Initial statement of beneficial ownership of securities  
07/08/2025 3:11 PM
Astley-Sparke Philip (1376491) Reporting
enGene (1980845) Issuer
Form 3
Initial statement of beneficial ownership of securities  
07/08/2025 3:13 PM
enGene (1980845) Issuer
Heffernan Michael Thomas (1448914) Reporting
Form 3
Initial statement of beneficial ownership of securities  
07/08/2025 3:08 PM
Buck Jill (1780426) Reporting
enGene (1980845) Issuer
Form 3
Initial statement of beneficial ownership of securities  
07/08/2025 7:09 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025 5:36 PM
Bos Jasper (1897789) Reporting
enGene (1980845) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:37 PM
BRUNK GERALD A (1380226) Reporting
enGene (1980845) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:38 PM
enGene (1980845) Issuer
Glickman Richard M (1352637) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:38 PM
enGene (1980845) Issuer
HASTINGS PAUL J (1309702) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
SpaceX is offering you shares. Don't take them. (Ad)

SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required.tc pixel

Get the backdoor ticker free before the SpaceX IPO launches
06/16/2025 5:39 PM
enGene (1980845) Issuer
Joustra Wouter (1897813) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:40 PM
enGene (1980845) Issuer
Pott Amy (1787363) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 5:40 PM
enGene (1980845) Issuer
Zoth Lota S. (1278219) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025 7:05 AM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2025 7:08 AM
enGene (1980845) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2025 4:26 PM
enGene (1980845) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

enGene SEC Filings - Frequently Asked Questions

enGene (ENGN) has submitted 161+ filings to the SEC since 2023. You can browse the complete history or filter by form type using the tools above.

enGene's fiscal year ends on October 31. The company typically files its 10-K annual report by the end of December, covering the prior fiscal year's financial results.

The most recent filing was a Form 8-K submitted on June 10, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:ENGN) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners